Skip to main content
Are we under-monitoring in scleroderma ILD?

Dr. Janet Pope discusses abstract 0678, Patients with Interstitial Lung Dis

Dr. John Cush RheumNow

1 year 10 months ago
Are we under-monitoring in scleroderma ILD? Dr. Janet Pope discusses abstract 0678, Patients with Interstitial Lung Disease Due to Systemic Sclerosis or Rheumatoid Arthritis Need Monitoring More Frequently Than Annually, and abstract 0706, Single Center Prospective Cohort of… https://t.co/1y1VXGvqjp https://t.co/4ofh45cYwq
Treatment Strategies in RA
Hypoxia seems to exacerbate neutrophil activation by ANCA

- enhanced F-Actin polymerization
- enhanced NET formation

Brian Jaros, MD Dr_Brian_MD

1 year 10 months ago
Hypoxia seems to exacerbate neutrophil activation by ANCA - enhanced F-Actin polymerization - enhanced NET formation Could hypoxia predilection in certain tissues (kidney, lung) lead to the AAV phenotypic disease patterns? @RheumNow #ACR24 https://t.co/KxaeMvkd2t
Prior studies have shown that IFN is increased in non-lesional skin of SLE pts.

In this study, they found a ⬆️ exp

sheila RHEUMarampa

1 year 10 months ago
Prior studies have shown that IFN is increased in non-lesional skin of SLE pts. In this study, they found a ⬆️ expression of IFN stimulated genes (ISGs) in pts w/ a history of CLE. No correlation w/ CLASI act & IFN scores but only few pts. @RheumNow #ACR24 abs2678 https://t.co/cPT6yPkoCb
Prof Petri reports the ff predictors of fracture in SLE:
-older age
-Caucasian race
-female sex

⚠️ Prednisone (but

sheila RHEUMarampa

1 year 10 months ago
Prof Petri reports the ff predictors of fracture in SLE: -older age -Caucasian race -female sex ⚠️ Prednisone (but not recent IM triamcinolone or IV methylpred) is a MAJOR risk factor. When possible, avoid prednisone! @RheumNow #ACR24 #ACRbest abs2679 @rheumarhyme https://t.co/q2NMRaYsAF
Lacaille et al. Long term harms of previous steroids in RA. CV/infection mortality increase 7% every year/use. Takes 3.5

Richard Conway RichardPAConway

1 year 10 months ago
Lacaille et al. Long term harms of previous steroids in RA. CV/infection mortality increase 7% every year/use. Takes 3.5 and 10 years to return to normal after 1 and 2 years use. Never returns to normal if >2 years use @RheumNow #ACR24 Abstr#2673 #ACRbest https://t.co/qcp5mCHmeB https://t.co/keXw5Qg2ld
All-caps abstract text throw-down by Michelle Petri re:fractures in SLE 😆

I keep saying this; our obsesssion with v

Mike Putman EBRheum

1 year 10 months ago
All-caps abstract text throw-down by Michelle Petri re:fractures in SLE 😆 I keep saying this; our obsesssion with vitamin d is not commensurate w/reality It's. The. Prednisone. #ACR24 @RheumNow Abstr#2679 #ACRBest https://t.co/13luByNvYT
What are the predictors of fracture in #SLE?

🦴Prednisone! Even at low doses ≤5mg
🦴Stroke
🦴Caucasian race
?

Mrinalini Dey DrMiniDey

1 year 10 months ago
What are the predictors of fracture in #SLE? 🦴Prednisone! Even at low doses ≤5mg 🦴Stroke 🦴Caucasian race 🦴Female 🦴Low BMD Try to avoid steroid use. If they are needed, IM triamcinolone or IVMP preferable to oral GC. Ab2679 #ACR24 @RheumNow
Does CVD mortality risk change after stopping GC in RA?
➡️28078 incident GC users
➡️Incr mortality risk from CVD

Mrinalini Dey DrMiniDey

1 year 10 months ago
Does CVD mortality risk change after stopping GC in RA? ➡️28078 incident GC users ➡️Incr mortality risk from CVD &infections persists post-cessation ➡️Risk never returns to pre-GC level after prolonged use ⏩Use GC at lowest dose for shortest time possible Ab2673 #ACR24 @Rheumnow https://t.co/dtLU8obLke
Increased risk of mortality related to negative effects of GC use persists long after stopping and never return to pre-G

Jiha Lee JihaRheum

1 year 10 months ago
Increased risk of mortality related to negative effects of GC use persists long after stopping and never return to pre-GC levels. #GCStewardship #ACR24 @RheumNow ABST#2673 https://t.co/5AwHDmvQGf
Ab2674 #ACR24
➡️Most pts starting 1st-line TNFi, who didn't achieve treatment response at 3M, also didn't achieve re

Mrinalini Dey DrMiniDey

1 year 10 months ago
Ab2674 #ACR24 ➡️Most pts starting 1st-line TNFi, who didn't achieve treatment response at 3M, also didn't achieve response from months 3-12 ➡️1/4 pts achieving LDA/remission at 3M were no longer in LDA/remission at 12M @RheumNow https://t.co/pFOo86tJTx
Data from the RISE registry show that 9.3% of SLE pts had thrombocytopenia and a smaller percentage with mod-severe TP (

sheila RHEUMarampa

1 year 10 months ago
Data from the RISE registry show that 9.3% of SLE pts had thrombocytopenia and a smaller percentage with mod-severe TP (2.7%). Severe TP was much rare. Large data, but well represented grp? @RheumNow #ACR24 abs2680 https://t.co/Y1Lo9lJGtO
An early favorable response to TNFi initiation indicates better long-term success in RA. Assess early and adjust treatme

Jiha Lee JihaRheum

1 year 10 months ago
An early favorable response to TNFi initiation indicates better long-term success in RA. Assess early and adjust treatment accordingly. #ACR24 @RheumNow ABST#2674 https://t.co/YTThYiiLpZ
#ACR24 BEST Abstracts from Day 1

The RheumNow faculty have parked at the plenaries, trafficked the posters and have bee

Dr. John Cush RheumNow

1 year 10 months ago
#ACR24 BEST Abstracts from Day 1 The RheumNow faculty have parked at the plenaries, trafficked the posters and have been finding the best the meeting offers on the first day. https://t.co/FHu616Jpyq https://t.co/oKuRcGRRAZ
Would you trust #AI to carry out & read your #USS?

2 systems, ARTHUR & DIANA, were comparable to that of a rheu

Mrinalini Dey DrMiniDey

1 year 10 months ago
Would you trust #AI to carry out & read your #USS? 2 systems, ARTHUR & DIANA, were comparable to that of a rheumatologist specialising in MSK US at joint & patient levels Might this be the future of assessment in rheumatology care? AbL20 #ACR24 @RheumNow https://t.co/XtnlYafzp4
×